Objective:

To explore the concept of corporate compliance in the pharmaceutical industry, emphasizing its implications for sustainability and ethical practices beyond mere regulatory requirements.

Key Findings:

• Corporate compliance is essential for fostering a culture of integrity and ethical responsibility.
• It should not be treated as a box-ticking exercise but as a means to add value to the organization.
• Compliance strategies must address risks beyond regulatory adherence, including sustainability and human rights.
• Effective compliance contributes to employee motivation and organizational credibility.

Interpretation:

Corporate compliance is a multifaceted approach requiring active engagement across all business functions, emphasizing ethical practices and stakeholder expectations.

Limitations:

• The article does not provide specific case studies or quantitative data to support claims.
• Challenges specific to different regions or markets are not fully explored.
• The impact of compliance on overall business performance is not discussed.

Conclusion:

A holistic approach to corporate compliance is crucial for pharmaceutical companies to meet regulatory expectations and foster a positive corporate culture.